Skip to main content

Advertisement

Table 1 Clinical and pathologic features of patients.

From: Claudin7 and moesin in endometrial Adenocarcinoma; a retrospective study of 265 patients

No. of evaluable patients 265
Follow time, year
Median 2.74
Age, year
Median 65
Range 29-97
Stage
I 174(66)
II 36(14)
III 36(14)
IV 19(7)
Subtype
Endometiriod 192(73)
USC+CCC 54(20)
Carcinosarcoma 19(7)
Grade(FIGO)
1 113(43)
2 49(18)
3 103(39)
Grade(Nuclear)
1 88(33)
2 70(26)
3 107(40)
Tumor size, cm
Median(Range) 4.58(0-33)
< = 2 53(20)
> 2 212(80)
Depth of myometrial invasion
Median(Range) 38.52(0-100)
< = 50 170(64)
> 50 95(36)
Lympho-vascular involvement
no 192(72)
yes 73(28)
Lymph Node Status  
yes 41(15)
no 119(45)
Not examined 105(40)
Recurrence  
no 209(79)
yes 42(16)
persistent 10(4)
progression 4(1)
Status  
ANED 202(76)
AWED 28(11)
DOD 22(8)
DNED 6(2)
DWED 4(2)
others 3(1)
MSN  
negative 143(54)
positive 122(46)
Claudin7  
negative 127(48)
positive 138(52)
  1. (Data in parentheses are percentages)